摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Hydroxy-3-(4-hydroxyphenyl)-7-propan-2-yloxychromen-4-one

中文名称
——
中文别名
——
英文名称
5-Hydroxy-3-(4-hydroxyphenyl)-7-propan-2-yloxychromen-4-one
英文别名
——
5-Hydroxy-3-(4-hydroxyphenyl)-7-propan-2-yloxychromen-4-one化学式
CAS
——
化学式
C18H16O5
mdl
——
分子量
312.3
InChiKey
GBXSXYPMIFTYHI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    76
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
    申请人:Southern Research Institute
    公开号:US10953017B2
    公开(公告)日:2021-03-23
    Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.
    本文描述了通过服用某些杂环化合物和芳香族化合物来增强记忆和/或学习能力并防止神经变性的方法。这些方法特别适用于治疗神经退行性疾病患者,如(但不限于)阿尔茨海默氏症、帕金森氏症、卢盖里氏症(ALS)或记忆或学习障碍。此外,还提供了一种基于神经元人体细胞的检测方法,利用荧光素酶报告物评估 NF-kB 基因的上调,从而筛选出在增强记忆或学习能力的方法中有用的化合物。
  • TREATMENT OF NEURODEGENERATIVE DISEASES, CAUSATION OF MEMORY ENHANCEMENT, AND ASSAY FOR SCREENING COMPOUNDS FOR SUCH
    申请人:Southern Research Institute
    公开号:US20160022691A1
    公开(公告)日:2016-01-28
    Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, and Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.
  • US9980969B2
    申请人:——
    公开号:US9980969B2
    公开(公告)日:2018-05-29
  • [EN] TREATMENT OF NEURODEGENERATIVE DISEASES, CAUSATION OF MEMORY ENHANCEMENT, AND ASSAY FOR SCREENING COMPOUNDS FOR SUCH<br/>[FR] TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES, CAUSE D'AMÉLIORATION DE LA MÉMOIRE ET ANALYSE POUR ÉVALUER DES COMPOSÉS ASSOCIÉS
    申请人:SOUTHERN RES INST
    公开号:WO2011047129A1
    公开(公告)日:2011-04-21
    Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, and Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.
查看更多